FDA Inspection 1266874 — Jiangsu Baozong & Baoda Pharmachem Co., Ltd.
The FDA completed an inspection of Jiangsu Baozong & Baoda Pharmachem Co., Ltd. on March 28, 2025 in Nantong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 28, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Nantong (China)